FDA Adverse Event Malfunction Summary report: N

COULTER® LH 780 HEMATOLOGY ANALYZER

MDR report key: 3230615 · Received July 16, 2013

Report

Report Number
1061932-2013-01398
Event Type
Malfunction
Date Received
July 16, 2013
Date of Event
June 24, 2013
Report Date
June 24, 2013
Manufacturer
BECKMAN COULTER
Product Code
GKZ
PMA / PMN Number
K061616
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NM, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A BECKMAN COULTER FSE (FIELD SERVICE ENGINEER) WAS DISPATCHED TO THE CUSTOMER'S SITE. THE FSE DISCOVERED THAT THE LEAK WAS NOT COMING FROM THE BSV, BUT WAS INSTEAD COMING FROM THE BLACK RINSE BLOCK ON THE PROBE WIPE ASSEMBLY. THE FSE REMOVED AND INSTALLED A NEW PROBE WIPE ASSEMBLY WHICH DID NOT WORK PROPERLY. THE FSE THEN CLEANED, REPAIRED, AND REINSTALLED THE OLD PROBE RINSE BLOCK ON THE PROBE WIPE ASSEMBLY. REPAIR WAS VERIFIED PER ESTABLISHED PROCEDURES AND RESULTS MET PUBLISHED SPECIFICATIONS. RESULTS: FAILURE MODE OF THE LEAK IS ATTRIBUTED TO THE BLACK RINSE BLOCK ON THE PROBE WIPE ASSEMBLY. BECKMAN COULTER INTERNAL IDENTIFIER FOR THIS REPORT IS (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT THE BSV (BLOOD SAMPLING VALVE) OF THE COULTER LH 780 HEMATOLOGY ANALYZER WAS LEAKING FLUID INTO THE DRIP TRAY. THE CUSTOMER STATED THAT GREEN COLORED FLUID WAS NOTICED IN THE DRIP TRAY WHILE PERFORMING WEEKLY MAINTENANCE ON THE INSTRUMENT. THE VOLUME OF THE LEAK IS UNKNOWN BUT THE LEAK WAS CONTAINED WITHIN THE INSTRUMENT. THE CUSTOMER WAS WEARING PERSONAL PROTECTIVE EQUIPMENT CONSISTING OF A LABORATORY COAT, FACE SHIELD, AND GLOVES AT THE TIME OF THE EVENT AND NO INJURY OR EXPOSURE WAS REPORTED. NO ERRONEOUS PATIENT RESULTS WERE GENERATED AND THERE WAS NO CHANGE OR AFFECT TO PATIENT TREATMENT IN CONNECTION WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
328071 COULTER® LH 780 HEMATOLOGY ANALYZER COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER NA NA

Patients

Seq Age Sex Outcome Treatment
1